Core Viewpoint - A securities class action lawsuit has been filed against Varonis Systems, Inc. and its executives, with a lead plaintiff deadline approaching on March 9, 2026, focusing on allegations of concealed issues in the company's transition to a Software-as-a-Service (SaaS) model [1][4]. Group 1: Allegations and Lawsuit Details - The lawsuit claims that Varonis executives failed to disclose significant renewal challenges in its Federal vertical and legacy on-premises business while promoting a smooth transition to SaaS [2][5]. - Following a disclosure on October 28, 2025, regarding difficulties in converting existing customers to the SaaS model, Varonis reported a 63.9% year-over-year decline in term license revenue and reduced its Annual Recurring Revenue (ARR) outlook, leading to a 48% drop in stock price, equating to a loss of approximately $3.8 billion in market value [3][9]. Group 2: Company Performance and Market Reaction - The lawsuit highlights a discrepancy between Varonis's optimistic statements about its SaaS transition and the actual struggles faced in its Federal renewal cycle and on-premises subscription business [5][9]. - After the Q3 performance miss, Varonis significantly reduced its Q4 revenue and full-year ARR guidance, which contributed to the sharp decline in stock value from $63.00 to $32.34 in a single day [9].

Core Viewpoint - The lawsuit against Plug Power, Inc. alleges that the company materially overstated the likelihood of receiving funds from a Department of Energy (DOE) loan and that it would pivot to less ambitious projects, impacting investor confidence and share prices [4]. Group 1: Lawsuit Details - The class action lawsuit is on behalf of investors who purchased Plug Power securities between January 17, 2025, and November 13, 2025 [4]. - Investors who suffered losses have until April 3, 2026, to request lead plaintiff appointment, which is crucial for overseeing the litigation [2]. - The lawsuit claims that Plug Power misrepresented the availability of DOE loan funds and the construction of hydrogen production facilities [4]. Group 2: Company Developments - On October 7, 2025, Plug Power announced the resignation of CEO Andrew Marsh and President Sanjay Shrestha, leading to a 6.3% decline in share price from $4.13 to $3.87 [5]. - Following an agreement for the immediate exercise of outstanding warrants, Plug Power raised approximately $370 million, but the share price fell by 5.4% from $3.87 to $3.66 [6]. - On November 10, 2025, the company reported financial results and announced a significant pivot by suspending activities under the DOE loan program, causing a 3.4% drop in share price from $2.65 to $2.56 [7]. - On November 13, 2025, it was reported that Plug Power confirmed the suspension of plans to construct hydrogen facilities, resulting in a 17.6% decline in share price from $2.73 to $2.25 [9].

Core Viewpoint - Hagens Berman is notifying investors about a pending securities class action against Klarna Group plc, focusing on alleged misstatements in the company's September 2025 IPO documents [1][4]. Group 1: Allegations and Investigation - The investigation centers on claims that Klarna's IPO documents misled investors by highlighting its strong credit modeling while failing to disclose aggressive lending practices to financially unsophisticated consumers [4][9]. - The lawsuit alleges that Klarna's offering documents materially understated the credit risks associated with lending to clients experiencing financial hardship [9]. - The complaint points out that Klarna's growth was driven by high-frequency, high-interest loans for non-durable goods, which critics argue target vulnerable consumers and increase default risks [9]. Group 2: Financial Impact - Following the IPO, Klarna reported a 102% year-over-year increase in its provision for credit losses, raising concerns about the transparency of its IPO documents [4][9]. - After the announcement of the increased credit loss provisions, Klarna's stock price fell nearly 22% below its IPO price, indicating a significant market reaction to the news [9]. Group 3: Next Steps for Investors - Investors who purchased Klarna shares during the September 2025 IPO and experienced losses are encouraged to contact Hagens Berman for assistance [3][6]. - The lead plaintiff deadline for the class action is set for February 20, 2026, prompting timely action from affected investors [7].

Core Viewpoint - A class action securities lawsuit has been filed against Picard Medical, Inc. for alleged securities fraud affecting investors between September 2, 2025, and October 31, 2025 [1][2] Group 1: Allegations of Fraud - The lawsuit claims that Picard Medical was involved in a fraudulent stock promotion scheme that utilized social media misinformation and impersonated financial professionals [2] - It is alleged that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [2] - The company's public statements and risk disclosures reportedly omitted any mention of false rumors and artificial trading activity that influenced the stock price [2] - As a result, the positive statements made by the defendants regarding the company's business, operations, and prospects were materially misleading and lacked a reasonable basis [2] Group 2: Legal Process and Participation - Investors who suffered losses in Picard Medical during the specified timeframe have until April 3, 2026, to request to be appointed as lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees, and participation does not require serving as a lead plaintiff [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has a strong track record in high-stakes securities litigation [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4]

Core Viewpoint - A class action securities lawsuit has been filed against Plug Power Inc. for alleged securities fraud affecting investors between January 17, 2025, and November 13, 2025 [1] Group 1: Lawsuit Details - The complaint alleges that defendants made false statements regarding the availability of funds from the U.S. Department of Energy's Loan Program, overstating the likelihood that these funds would be accessible to Plug Power [2] - It is claimed that Plug Power was likely to shift towards less ambitious projects with lower commercial potential, contradicting public statements made by the company [2] - The lawsuit asserts that the company's public statements were materially false and misleading throughout the relevant period [2] Group 2: Next Steps for Investors - Investors who suffered losses in Plug Power during the specified timeframe have until April 3, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3] - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the U.S. for seven consecutive years [4]

NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in agilon health, inc. ("agilon health, inc." or the "Company") (NYSE: AGL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of agilon health, inc. investors who were adversely affected by alleged securities fraud between February 26, 2025 and August 4, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/ag ...

Core Viewpoint - A class action securities lawsuit has been filed against Ultragenyx Pharmaceutical Inc. for alleged securities fraud affecting investors between August 3, 2023, and December 26, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that Ultragenyx made misleading statements regarding the efficacy of setrusumab, particularly that while it increases bone density, it does not correlate with a decrease in annualized fracture rates [2] - On December 29, 2025, Ultragenyx announced that its Phase III Orbit and Cosmic Studies did not achieve statistical significance in reducing annualized clinical fracture rates compared to placebo or bisphosphonates [2] - Following this announcement, Ultragenyx's stock price plummeted from $34.19 per share on December 26, 2025, to $19.72 per share on December 29, 2025, marking a decline of approximately 42.32% in one day [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until April 6, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]

Core Viewpoint - A class action securities lawsuit has been filed against Bath & Body Works, Inc. alleging securities fraud that affected investors between June 4, 2024, and November 9, 2025 [1] Group 1: Allegations of the Lawsuit - The lawsuit claims that the company's strategy of pursuing "adjacencies, collaborations and promotions" did not effectively grow the customer base or deliver the expected growth in net sales [2] - It is alleged that as the company's strategy faltered, it relied on brand collaborations to mask weak underlying financial results [2] - The lawsuit contends that the company was unlikely to meet its previously issued financial guidance due to these issues, rendering positive statements about its business and prospects materially misleading [2] Group 2: Next Steps for Affected Investors - Investors who suffered losses during the specified time frame have until March 13, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require serving as lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4]

Core Viewpoint - A class action securities lawsuit has been filed against Coupang, Inc. for alleged securities fraud affecting investors between May 7, 2025, and December 16, 2025 [1][2]. Group 1: Allegations - The lawsuit claims that Coupang had inadequate cybersecurity protocols, allowing a former employee to access sensitive customer information for nearly six months without detection [2]. - It is alleged that this data breach exposed Coupang to increased regulatory and legal scrutiny [2]. - The defendants reportedly failed to disclose the data breach in a timely manner as required by SEC reporting rules, leading to materially false and misleading public statements [2]. Group 2: Legal Process - Investors who suffered losses during the specified timeframe have until February 17, 2026, to request appointment as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the U.S. [4]. - The firm has over 70 employees dedicated to serving clients in complex securities litigation [4].

Core Viewpoint - An investigation has been initiated by Levi & Korsinsky into Gartner, Inc. regarding potential violations of federal securities laws, particularly focusing on the company's financial disclosures and earnings guidance [1][2]. Financial Performance and Disclosures - Gartner's fourth quarter earnings release on February 3, 2026, highlighted an earnings-per-share (EPS) beat against analyst estimates, but simultaneously revealed that revenue fell short of consensus expectations [2]. - The company provided a full-year 2026 outlook indicating a year-over-year decline, raising concerns about the transparency of its financial metrics [2]. - Gartner had previously guided investors to expect adjusted EPS of at least $12.65 for 2025, based on 78 million shares and anticipated stock repurchases to offset dilution [2]. - The company repurchased over $1 billion of stock during Q3 2025, resulting in a 6% reduction in share count year-over-year [2]. Market Reaction - Following the earnings release, Gartner's shares experienced a decline of more than 20%, reaching a new 52-week low below $160, with trading volume significantly exceeding normal levels [2].